The Journal of Law, Medicine and Ethics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Practical Steps to Community Engaged Research: From Inputs to Outcomes
For decades, the dominant research paradigm has included trials conducted in clinical settings with little involvement from communities. The move toward community engaged research (CEnR) necessitates the inclusion of diverse perspectives to address complex problems. Using a relationship paradigm, CEnR reframes the context, considerations, practical steps, and outcomes of research. (Source: The Journal of Law, Medicine and Ethics)
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Malika Roman Isler, Giselle Corbie‐Smith Source Type: research

Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era
Disparities in access to, and utilization of, treatment for depression among African‐American and Caucasian elderly adults have been well‐documented. Less fully explored are the multidimensional factors responsible for these disparities. The intersection of cultural constructs, socioeconomic factors, multiple levels of racism, and stigma attending both mental health issues and older age may help to explain disparities in the treatment of the depressed elderly. Personalized medicine with its promise of developing interventions tailored to an individual's health needs and genetically related response to treatment might s...
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Lisa S. Parker, Valerie B. Satkoske Source Type: research

The Troubling Persistence of Race in Pharmacogenomics
This article is concerned about what may be happening to race and medicine in the “meantime” between today's clinical realities and the promised land of pharmacogenomics where the need for using race in medicine is supposed to fade away. It argues that previous debates over the use of race in medicine are being side‐stepped as race is being reconfigured from a “crude surrogate” for genetic variation into a purportedly viable placeholder for variable drug response — to be used here and now until the specific genetic underpinnings of drug response are more fully understood. Embracing the trope of “promise” in...
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Jonathan Kahn Source Type: research